Literature DB >> 30083953

Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.

Anastasia Bougea1,2, Leonidas Stefanis3,4, George P Paraskevas3, Evangelia Emmanouilidou4, Efthimia Efthymiopoulou3, Kostas Vekrelis4, Elisabeth Kapaki3.   

Abstract

INTRODUCTION: Given the overlapping of neuropathological, neurochemical and neuropsychiatric profiles of Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB) and Alzheimer's disease (AD), their differential diagnosis is challenging. Specific neuropsychiatric features or biomarkers, such as cerebrospinal fluid (CSF) α-Synuclein (α-Syn), may aid in differential diagnosis. This study aims to compare the neuropsychiatric and CSF α-Syn profiles in these conditions, and to investigate the possible association between CSF α-Syn levels and neuropsychiatric symptoms.
METHODS: We conducted a prospective cross-sectional study, between January 2013 and January 2015, with 16 PDD, 28 DLB and 19 AD patients. All participants underwent a detailed clinical, neuropsychological, neuropsychiatric [Neuropsychiatric Inventory (NPI)] and CSF α-Syn analysis.
RESULTS: Significantly greater NPI Hallucinations Subitem score was found in the PDD and DLB groups compared to AD (both p < 0.001). NPI Agitation score was greater in the DLB compared to PDD group (p = 0.012). NPI Sleep score was greater in the DLB compared to AD group (p = 0.001). Total NPI score was greater in the DLB compared to AD and PDD groups. To discriminate between the DLB and AD and between DLB and PDD groups, logistic regression analysis showed that both NPI scores and α-Syn levels were independently associated. There was no correlation between NPI scores and α-Syn levels. Increased NPI scores and α-Syn levels are associated with greater likelihood for being in DLB than in PDD or AD groups. ROC analysis showed that the combination of NPI and α-Syn increases the discriminative ability of each marker alone (p < 0.001) with AUC equal to 0.95 (95% CI 0.91-0.99).
CONCLUSION: NPI scores and CSF α-Syn levels were useful as independent variables to differentiate DLB from PDD and AD.

Entities:  

Keywords:  Alzheimer’s disease (AD); Dementia with Lewy bodies (DLB); Neuropsychiatric Inventory (NPI); Parkinson’s disease dementia (PDD); α-Synuclein (α-Syn)

Mesh:

Substances:

Year:  2018        PMID: 30083953     DOI: 10.1007/s00415-018-8992-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.

Authors:  S E Starkstein; L Sabe; G Petracca; E Chemerinski; G Kuzis; M Merello; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

2.  Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

Authors:  R H Perry; D Irving; G Blessed; A Fairbairn; E K Perry
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

3.  Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Authors:  Sara Hall; Annika Öhrfelt; Radu Constantinescu; Ulf Andreasson; Yulia Surova; Frederick Bostrom; Christer Nilsson; Widner Håkan; Hilde Decraemer; Katarina Någga; Lennart Minthon; Elisabet Londos; Eugeen Vanmechelen; Björn Holmberg; Henrik Zetterberg; Kaj Blennow; Oskar Hansson
Journal:  Arch Neurol       Date:  2012-11

4.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Enrique Noe; Karen Marder; Karen L Bell; Diane M Jacobs; Jennifer J Manly; Yaakov Stern
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

5.  Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria.

Authors:  Dag Aarsland; Arvid Rongve; Sabine Piepenstock Nore; Ragnhild Skogseth; Siri Skulstad; Uwe Ehrt; Dagne Hoprekstad; Clive Ballard
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-31       Impact factor: 2.959

6.  Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic.

Authors:  Antonis M Politis; Lawrence S Mayer; Maria Passa; Antonis Maillis; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2004-03       Impact factor: 3.485

7.  Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.

Authors:  Dagmar H Hepp; Dana L E Vergoossen; Evelien Huisman; Afina W Lemstra; Henk W Berendse; Annemieke J Rozemuller; Elisabeth M J Foncke; Wilma D J van de Berg
Journal:  J Neuropathol Exp Neurol       Date:  2016-08-11       Impact factor: 3.685

8.  Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.

Authors:  Pravat K Mandal; Jay W Pettegrew; Eliezer Masliah; Ronald L Hamilton; Ratna Mandal
Journal:  Neurochem Res       Date:  2006-09-01       Impact factor: 4.414

9.  Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study.

Authors:  Pai-Yi Chiu; Chun-Tang Tsai; Ping-Kun Chen; Whe-Jen Chen; Te-Jen Lai
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

10.  The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.

Authors:  Elisabeth Kapaki; George P Paraskevas; Evangelia Emmanouilidou; Kostas Vekrellis
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more
  4 in total

1.  Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies.

Authors:  Aikaterini Foska; Ioanna Tsantzali; Eleni Sideri; Maria Ioanna Stefanou; Eleni Bakola; Dimitrios K Kitsos; Christina Zompola; Anastasios Bonakis; Sotirios Giannopoulos; Konstantinos I Voumvourakis; Georgios Tsivgoulis; George P Paraskevas
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

2.  Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.

Authors:  Emilia Schwertner; Joana B Pereira; Hong Xu; Juraj Secnik; Bengt Winblad; Maria Eriksdotter; Katarina Nägga; Dorota Religa
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Alzheimer's disease and dementia with Lewy bodies.

Authors:  Saira Saeed Mirza; Usman Saeed; Joel Ramirez; Nathan Herrmann; Donald T Stuss; Sandra E Black; Mario Masellis
Journal:  Alzheimers Dement (Amst)       Date:  2022-05-02

Review 4.  Lewy Body Dementias: A Coin with Two Sides?

Authors:  Ángela Milán-Tomás; Marta Fernández-Matarrubia; María Cruz Rodríguez-Oroz
Journal:  Behav Sci (Basel)       Date:  2021-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.